{"id":48040,"date":"2023-04-25T10:43:37","date_gmt":"2023-04-25T05:13:37","guid":{"rendered":"http:\/\/finservwealth.com\/subscribe-to-mankind-pharma-icici-direct\/"},"modified":"2023-04-25T10:43:37","modified_gmt":"2023-04-25T05:13:37","slug":"subscribe-to-mankind-pharma-icici-direct","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/subscribe-to-mankind-pharma-icici-direct\/","title":{"rendered":"Subscribe to Mankind Pharma: ICICI Direct"},"content":{"rendered":"<p> ICICI Direct has come out with its report on Mankind Pharma. The research firm has recommended to \u00e2\u20ac\u0153 Subscribe \u00e2\u20ac\ufffd the ipo in its research report as on April 24, 2023.<\/p><div id=\"finse-3010980400\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-issues-open\/subscribe-to-mankind-pharma-icici-direct_16970441.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0ICICI Direct has come out with its report on Mankind Pharma. The research firm has recommended to \u00e2\u20ac\u0153 Subscribe \u00e2\u20ac\ufffd the ipo in its research report as on April 24, 2023. ICICI Direct has come out with its report on Mankind Pharma. The research firm has recommended to \u00e2\u20ac\u0153 Subscribe \u00e2\u20ac\ufffd the ipo in its research report as on April 24, 2023.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-issues-open\/subscribe-to-mankind-pharma-icici-direct_16970441.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> ICICI Direct has come out with its report on Mankind Pharma. The research firm has recommended to \u00e2\u20ac\u0153 Subscribe \u00e2\u20ac\ufffd the ipo in its research report as on April 24, 2023.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-issues-open\/subscribe-to-mankind-pharma-icici-direct_16970441.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0ICICI Direct has come out with its report on Mankind Pharma. The research firm has recommended to \u00e2\u20ac\u0153 Subscribe \u00e2\u20ac\ufffd the ipo in its research report as on April 24, 2023. ICICI Direct has come out with its report on Mankind Pharma. The research firm has recommended to \u00e2\u20ac\u0153 Subscribe \u00e2\u20ac\ufffd the ipo in its research report as on April 24, 2023.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-issues-open\/subscribe-to-mankind-pharma-icici-direct_16970441.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> ICICI Direct has come out with its report on Mankind Pharma. The research firm has recommended to \u00e2\u20ac\u0153 Subscribe \u00e2\u20ac\ufffd the ipo in its research report as on April 24, 2023.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-48040","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2022\/200x200\/I\/IPO-2_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/48040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=48040"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/48040\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=48040"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=48040"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=48040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}